Percutaneous coronary intervention of the left main coronary artery has evolved through registries and meta analyses, supported by results from the EXCEL [Everolimus-Eluting Stents (EES) or Bypass Surgery for Left Main Coronary Artery Disease] and NOBLE (Percutaneous Coronary Angioplasty versus Coronary Artery Bypass Grafting in Treatment of Unprotected Left Main Stenosis) trials as an acceptable alternative to coronary artery bypass grafting in patients with low and intermediate Syntax scores. Advances in stenting strategies and the availability of larger diameter drug-eluting stents improve patient safety and optimize procedural and patient outcomes.

中文翻译：

---

左主干疾病：什么是正确的血运重建方法？

左主冠状动脉的经皮冠状动脉介入治疗已经通过登记和荟萃分析发展起来，并得到了EXCEL [依维莫司洗脱支架（EES）或左主冠状动脉疾病旁路手术]和NOBLE（经皮冠状动脉血管成形术与冠状动脉造影术）对于无中度和低Syntax评分的患者，在无保护的左主动脉狭窄的治疗中使用旁路移植术可以替代冠状动脉旁路移植术。支架策略的进步和更大直径药物洗脱支架的可用性提高了患者的安全性，并优化了程序和患者的治疗效果。